MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05564390 | RECRUITING | PHASE2
2000 participants

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-06-18
Completion:
2029-05-15
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Acute Myeloid Leukemia, Myelodysplasia-Related
  • Myelodysplastic Syndrome
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT05554328 | RECRUITING | PHASE2
165 participants

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-04-25
Completion:
2028-10-01
Conditions
  • Recurrent Endometrial Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05442515 | RECRUITING | PHASE1/PHASE2
126 participants

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2022-12-28
Completion:
2027-07-01
Conditions
  • B-NHL
  • B-Non Hodgkin Lymphoma
  • Acute Lymphocytic Leukemia
  • Acute Lymphoblastic Leukemia
  • B-precursor ALL
  • B-All
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, B Cell
  • B-Cell Lymphoma
  • B-Cell Leukemia
  • Acute Lymphoid Leukemia
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05412901 | SUSPENDED | NA
170 participants

Scaffolding of Brain Operations

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2022-04-10
Completion:
2027-06-30
Conditions
  • Behavioral Performance
Interventions
  • OTHER
No Results Yet
NCT05319730 | RECRUITING | PHASE1/PHASE2
230 participants

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-05-16
Completion:
2027-06-11
Conditions
  • Esophageal Squamous Cell Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05256225 | RECRUITING | PHASE3
360 participants

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2022-11-16
Completion:
2027-10-31
Conditions
  • Endometrial Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Dedifferentiated Carcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page